.png){kind=logo}
Celestia was one of the highest gainers throughout last year after it racked up a total of 764% in gains, moving its price from its $2 range at the time to its current $18 to $20 range. Asides from its skyrocketing price, Celestia TVL and market cap are also reflecting green signals.
On the other hand, while Injective also ranks among the top crypto coins with the highest gains last year, the native INJ token is taking a beating as bullish pressure forces its price to decline. Meanwhile, Pullix crypto has already set the pace for continued success after its launch in a few weeks time. The new hybrid cryptocurrency has racked up 15,000 users becoming the best new crypto to invest in.
Celestia began this year by pricing around a $13 to $14 range. However the token has been able to rise up throughout the month, increasing by 24.65%. Despite a series of fluctuations throughout January, Celestia prevailed by going through a couple of bullish cycles.
In the past week, Celestia price increased by 3.25%, operating at a weekly price range of $15.8 to $18.5. Currently Celestia is forming another bullish trend as it shows potential of surging upwards further increasing its value.
Asides from its weekly and monthly price gain, Celestia has also increased in market cap, gaining 6.54% recently, with a current market cap of $2.9 billion. The TVL of Celestia has also just recently gained 20.51% extra value.
The price of Injective token is currently holding a weekly range of $33 to $36. However, considering the pressure of the bearish sentiment Injective is currently facing, the potential for a further decrease is high. Injective has lost 9.49% in value in the space of 7 days.
Looking at the monthly chart of Injective, the token has significantly reduced by 7.91% despite pricing at a peak price of $44.2 sometime in January. However, since Injective started to decline late last month, it slowly succumbed to bearish sentiments.
Currently, Injective token is pricing below its weekly support threshold of $36.9, however, it might be able to experience a comeback in due time if volatility favors Injective's network.
With a substantial user base of over 15,000 users, Pullix (PLX) has gained notable traction that fueled its widespread user engagement. The project's innovative Profit Share Model, which provides users with a unique incentive structure, has further heightened investor interest in Pullix.
Essentially, Pullix is a new hybrid cryptocurrency platform that combines DeFi and CeFi elements in an attempt to tackle liquidity issues peculiar to online trading platforms, including decentralized exchanges and traditional exchange markets. Scheduled for launch in a few weeks time, Pullix is strategically positioning itself among the best new crypto to invest in this year as it's poised for a potential price surge.
Interestingly, to fortify the stability of its native PLX token, Pullix takes a proactive approach by allocating a substantial portion of the platform's daily revenue, ranging from 10% to 30%, to support this altcoin.
Looking ahead, Pullix boasts strong potential to become one of the best crypto investments for the year, considering its robust statistics and promising prospects. Currently in its seventh stage presale at $0.10, it has successfully raised over $5 million as it makes advances into its last presale stage.
For more information regarding Pullix's presale see links below:
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.
